日本語 
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that is basically aimed at one thing. Making antibody-drug conjugate work move faster from early development to actual commercial…
A.D.A.M. Innovations Reveals the New ALUNAÉ Platform
A.D.A.M. Innovations is rolling out ALUNAÉ, a skincare line built on genomic…
FIZE Launches Real-Time Kidney Monitoring in Japan
FIZE Medical is taking a clear step into the Japanese market by…
Kura and Kyowa Report Strong KOMZIFTI AML Data
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
MOTHER Labs Joins TD SYNNEX to Expand in Japan
MEDIROM Healthcare Technologies says its health tech arm MOTHER Labs has signed…
Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
KSK Unveils “Tsunagu TV” Health & Medical Platform
KSK Corporation will release the video platform "Tsunagu TV" in December. "Tsunagu…
Ubie and Kameda Hospital Start AI Obesity Treatment PoC
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan
Eisai and its global partner Biogen have filed a new drug application…
A.D.A.M. Innovations Reveals the New ALUNAÉ Platform
A.D.A.M. Innovations is rolling out ALUNAÉ, a skincare line built on genomic…
FIZE Launches Real-Time Kidney Monitoring in Japan
FIZE Medical is taking a clear step into the Japanese market by…
Kura and Kyowa Report Strong KOMZIFTI AML Data
Kura Oncology and Kyowa Kirin rolled out fresh data on KOMZIFTI ziftomenib…
MOTHER Labs Joins TD SYNNEX to Expand in Japan
MEDIROM Healthcare Technologies says its health tech arm MOTHER Labs has signed…
Meiji Seika Pharma Supports Lyric Bio in Ig Manufacturing
Meiji Seika Pharma Co., Ltd. announced a strategic equity investment in Lyric…
KSK Unveils “Tsunagu TV” Health & Medical Platform
KSK Corporation will release the video platform "Tsunagu TV" in December. "Tsunagu…
Ubie and Kameda Hospital Start AI Obesity Treatment PoC
Ubie Inc. is pleased to announce that, in collaboration with Kameda General…
Eisai Seeks Approval for Subcutaneous LEQEMBI in Japan
Eisai and its global partner Biogen have filed a new drug application…
English